...
首页> 外文期刊>Chembiochem: A European journal of chemical biology >Artifact-Free Quantification and Sequencing of Rare Recombinant Viruses by Using Drop-Based Microfluidics
【24h】

Artifact-Free Quantification and Sequencing of Rare Recombinant Viruses by Using Drop-Based Microfluidics

机译:使用基于液滴的微流控技术对稀有重组病毒进行无伪像定量和测序

获取原文
获取原文并翻译 | 示例
           

摘要

Recombination is an important driver in the evolution of viruses and thus is key to understanding viral epidemics and improving strategies to prevent future outbreaks. Characterization of rare recombinant subpopulations remains technically challenging because of artifacts such as artificial recombinants, known as chimeras, and amplification bias. To overcome this, we have developed a high-throughput microfluidic technique with a second verification step in order to amplify and sequence single recombinant viruses with high fidelity in picoliter drops. We obtained the first artifact-free estimate of in vitro recombination rate between murine norovirus strains MNV-1 and WU20 co-infecting a cell (P-rec=3.3x10(-4) +/- 2 x 10(-5)) for a 1205 nt region. Our approach represents a time-and cost-effective improvement over current methods, and can be adapted for genomic studies requiring artifact-and bias-free selective amplification, such as microbial pathogens, or rare cancer cells.
机译:重组是病毒进化的重要驱动力,因此对于理解病毒流行和改进预防未来爆发的策略至关重要。由于伪影(例如称为嵌合体的人工重组体)和扩增偏差,对稀有重组亚群的表征在技术上仍然具有挑战性。为了克服这个问题,我们开发了一种高通量的微流体技术,并具有第二个验证步骤,以便在皮升滴剂中以高保真度扩增和测序单个重组病毒。我们获得了鼠诺如病毒株MNV-1和WU20共感染细胞(P-rec = 3.3x10(-4)+/- 2 x 10(-5))的体外重组率的第一个无假象估计1205 nt区域。我们的方法代表了对当前方法的时间和成本效益的改进,并且可以适用于需要无伪影和无偏差选择性扩增的基因组研究,例如微生物病原体或稀有癌细胞。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号